NR1I3 and cancer: Constitutive androstane receptor (CAR, NR1I3), a member of the superfamily of nuclear receptors, is a xenobiotic receptor responsible for the regulation of drug metabolism as well as the pathological involvement of various diseases such as cancer, diabetes, inflammatory disease, metabolic disease and liver disease, suggesting a potential target for drug discovery [1].